Search research articles
Contact Us
Filters
Showing results (21-30 of 65) with videos related to
Page
of 7
Sort By:
Journal of Clinical Microbiology
|
December 1, 1982
Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei
R J Wallace, J M Swenson, V A Silcox, et al.
The Journal of Infectious Diseases
|
September 1, 1985
Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities
R J Wallace, J M Swenson, V A Silcox, et al.
Diagnostic Microbiology and Infectious Disease
|
May 1, 1987
Mechanism of aminoglycoside resistance among beta-lactam-resistant Escherichia coli in the United States
R P Gaynes, R Cooksey, C Thornsberry, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1983
Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics
M S Stone, R J Wallace, J M Swenson, et al.
Antimicrobial Agents and Chemotherapy
|
December 31, 1998
Detection of a streptomycin/spectinomycin adenylyltransferase gene (aadA) in Enterococcus faecalis
N C Clark, O Olsvik, J M Swenson, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1980
Susceptibility of Clostridium botulinum to thirteen antimicrobial agents
J M Swenson, C Thornsberry, L M McCroskey, et al.
Journal of Clinical Microbiology
|
September 28, 2001
Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms
J M Swenson, P P Williams, G Killgore, et al.
Journal of Clinical Microbiology
|
October 1, 1992
New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci
J M Swenson, M J Ferraro, D F Sahm, et al.
Antimicrobial Agents and Chemotherapy
|
January 30, 1999
Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci
J H Jorgensen, L M Weigel, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1984
Susceptibilities of Mycobacterium fortuitum biovariant fortuitum and the unnamed third biovariant complex to heavy-metal salts
R J Wallace, L C Steele, G D Forrester, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 65) with videos related to
Sort By:
Page
of 7
Journal of Clinical Microbiology
|
December 1, 1982
Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei
R J Wallace, J M Swenson, V A Silcox, et al.
The Journal of Infectious Diseases
|
September 1, 1985
Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities
R J Wallace, J M Swenson, V A Silcox, et al.
Diagnostic Microbiology and Infectious Disease
|
May 1, 1987
Mechanism of aminoglycoside resistance among beta-lactam-resistant Escherichia coli in the United States
R P Gaynes, R Cooksey, C Thornsberry, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1983
Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics
M S Stone, R J Wallace, J M Swenson, et al.
Antimicrobial Agents and Chemotherapy
|
December 31, 1998
Detection of a streptomycin/spectinomycin adenylyltransferase gene (aadA) in Enterococcus faecalis
N C Clark, O Olsvik, J M Swenson, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1980
Susceptibility of Clostridium botulinum to thirteen antimicrobial agents
J M Swenson, C Thornsberry, L M McCroskey, et al.
Journal of Clinical Microbiology
|
September 28, 2001
Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms
J M Swenson, P P Williams, G Killgore, et al.
Journal of Clinical Microbiology
|
October 1, 1992
New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci
J M Swenson, M J Ferraro, D F Sahm, et al.
Antimicrobial Agents and Chemotherapy
|
January 30, 1999
Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci
J H Jorgensen, L M Weigel, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1984
Susceptibilities of Mycobacterium fortuitum biovariant fortuitum and the unnamed third biovariant complex to heavy-metal salts
R J Wallace, L C Steele, G D Forrester, et al.
Page
of 7